{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:39:33Z","timestamp":1761100773340},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T00:00:00Z","timestamp":1107129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T00:00:00Z","timestamp":1107129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1038\/sj.bmt.1704776","type":"journal-article","created":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T10:10:50Z","timestamp":1107166250000},"page":"549-556","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients"],"prefix":"10.1038","volume":"35","author":[{"given":"T","family":"Hamaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Yuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Murashige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Uoshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,31]]},"reference":[{"key":"BF1704776_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2141.1994.tb03252.x","volume":"86","author":"F Giona","year":"1994","unstructured":"Giona F, Testi AM, Annino L et al. Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA\/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica. Br J Haematol 1994; 86: 55\u201361.","journal-title":"Br J Haematol"},{"key":"BF1704776_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(87)92809-1","volume":"1","author":"RH Herzig","year":"1987","unstructured":"Herzig RH, Bortin MM, Barrett AJ et al. Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. Lancet 1987; 1: 786\u2013789.","journal-title":"Lancet"},{"key":"BF1704776_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2141.1989.tb07642.x","volume":"72","author":"A Butturini","year":"1989","unstructured":"Butturini A, Gale RP . Chemotherapy versus transplantation in acute leukaemia. Br J Haematol 1989; 72: 1\u20138.","journal-title":"Br J Haematol"},{"key":"BF1704776_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.7326\/0003-4819-115-1-13","volume":"115","author":"MM Horowitz","year":"1991","unstructured":"Horowitz MM, Messerer D, Hoelzer D et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991; 115: 13\u201318.","journal-title":"Ann Intern Med"},{"key":"BF1704776_CR5","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","volume":"11","author":"D Fiere","year":"1993","unstructured":"Fiere D, Lepage E, Sebban C et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. J Clin Oncol 1993; 11: 1990\u20132001.","journal-title":"J Clin Oncol"},{"key":"BF1704776_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.bmt.1703899","volume":"31","author":"I Avivi","year":"2003","unstructured":"Avivi I, Goldstone AH . Bone marrow transplant in Ph+ ALL patients. Bone Marrow Transplant 2003; 31: 623\u2013632.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR7","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","volume":"87","author":"S Slavin","year":"1996","unstructured":"Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195\u20132204.","journal-title":"Blood"},{"key":"BF1704776_CR8","first-page":"331","volume":"14","author":"A Ferster","year":"1994","unstructured":"Ferster A, Bujan W, Mouraux T et al. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant 1994; 14: 331\u2013332.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"issue":"Suppl. 4","key":"BF1704776_CR10","first-page":"S15","volume":"11","author":"FR Appelbaum","year":"1997","unstructured":"Appelbaum FR . Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). Leukemia 1997; 11 (Suppl. 4): S15\u2013S17.","journal-title":"Leukemia"},{"key":"BF1704776_CR11","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","volume":"97","author":"JJ Cornelissen","year":"2001","unstructured":"Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97: 1572\u20131577.","journal-title":"Blood"},{"key":"BF1704776_CR12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BF1704776_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","volume":"26","author":"RH Collins Jr","year":"2000","unstructured":"Collins Jr RH, Goldstein S, Giralt S et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant 2000; 26: 511\u2013516.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BF1704776_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631\u2013637.","journal-title":"Blood"},{"key":"BF1704776_CR16","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BF1704776_CR17","first-page":"2254","volume":"7","author":"M Bornhauser","year":"2001","unstructured":"Bornhauser M, Thiede C, Platzbecker U et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res 2001; 7: 2254\u20132262.","journal-title":"Clin Cancer Res"},{"key":"BF1704776_CR18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"D Niederwieser","year":"2003","unstructured":"Niederwieser D, Maris M, Shizuru JA et al Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101: 1620\u20131629.","journal-title":"Blood"},{"key":"BF1704776_CR19","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","volume":"102","author":"MB Maris","year":"2003","unstructured":"Maris MB, Niederwieser D, Sandmaier BM et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021\u20132030.","journal-title":"Blood"},{"key":"BF1704776_CR20","first-page":"479a","volume":"96","author":"K Rezvani","year":"2000","unstructured":"Rezvani K, Lalancette M, Szydlo R et al. Non-myeloablative stem cell transplant (NMSCT) in AML, ALL and MDS: disappointing outcome for patients with advanced phase disease. Blood 2000; 96: 479a.","journal-title":"Blood"},{"key":"BF1704776_CR21","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/sj.leu.2402712","volume":"16","author":"R Arnold","year":"2002","unstructured":"Arnold R, Massenkeil G, Bornhauser M et al. Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia 2002; 16: 2423\u20132428.","journal-title":"Leukemia"},{"key":"BF1704776_CR22","first-page":"555","volume":"88","author":"R Martino","year":"2003","unstructured":"Martino R, Giralt S, Caballero MD et al. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica 2003; 88: 555\u2013560.","journal-title":"Haematologica"},{"key":"BF1704776_CR23","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","volume":"19","author":"M Michallet","year":"2001","unstructured":"Michallet M, Bilger K, Garban F et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 2001; 19: 3340\u20133349.","journal-title":"J Clin Oncol"},{"key":"BF1704776_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ajh.1051","volume":"66","author":"GJ Ruiz-Arguelles","year":"2001","unstructured":"Ruiz-Arguelles GJ, Gomez-Almaguer D, Ruiz-Arguelles A et al. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens. Am J Hematol 2001; 66: 241\u2013244.","journal-title":"Am J Hematol"},{"key":"BF1704776_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJM200009143431101","volume":"343","author":"R Childs","year":"2000","unstructured":"Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750\u2013758.","journal-title":"N Engl J Med"},{"key":"BF1704776_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bmt.1703355","volume":"29","author":"A Bacigalupo","year":"2002","unstructured":"Bacigalupo A . Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). Bone Marrow Transplant 2002; 29: 191\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/sj.bmt.1704416","volume":"33","author":"A Bacigalupo","year":"2004","unstructured":"Bacigalupo A . Third EBMT\/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant 2004; 33: 691\u2013696.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1704776_CR29","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BF1704776_CR31","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1200\/JCO.1987.5.9.1348","volume":"5","author":"DJ Weisdorf","year":"1987","unstructured":"Weisdorf DJ, Nesbit ME, Ramsay NK et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J Clin Oncol 1987; 5: 1348\u20131355.","journal-title":"J Clin Oncol"},{"key":"BF1704776_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJM198708203170801","volume":"317","author":"JH Kersey","year":"1987","unstructured":"Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 317: 461\u2013467.","journal-title":"N Engl J Med"},{"key":"BF1704776_CR33","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/sj.leu.2402552","volume":"16","author":"P Bader","year":"2002","unstructured":"Bader P, Hancock J, Kreyenberg H et al. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 2002; 16: 1668\u20131672.","journal-title":"Leukemia"},{"key":"BF1704776_CR34","first-page":"453","volume":"7","author":"K Doney","year":"1991","unstructured":"Doney K, Fisher LD, Appelbaum FR et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991; 7: 453\u2013459.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR35","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1200\/JCO.1991.9.9.1570","volume":"9","author":"SJ Forman","year":"1991","unstructured":"Forman SJ, Schmidt GM, Nademanee AP et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. J Clin Oncol 1991; 9: 1570\u20131574.","journal-title":"J Clin Oncol"},{"key":"BF1704776_CR36","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/sj.leu.2401581","volume":"13","author":"P Bader","year":"1999","unstructured":"Bader P, Klingebiel T, Schaudt A et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999; 13: 2079\u20132086.","journal-title":"Leukemia"},{"key":"BF1704776_CR37","first-page":"241","volume":"18","author":"B Lonnqvist","year":"1996","unstructured":"Lonnqvist B, Brune M, Ljungman P . Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML \u2013 a case report. Bone Marrow Transplant 1996; 18: 241\u2013242.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704776_CR38","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1182\/blood-2003-05-1597","volume":"102","author":"T Fukuda","year":"2003","unstructured":"Fukuda T, Hackman RC, Guthrie KA et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102: 2777\u20132785.","journal-title":"Blood"},{"key":"BF1704776_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","volume":"102","author":"M Mielcarek","year":"2003","unstructured":"Mielcarek M, Martin PJ, Leisenring W et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756\u2013762.","journal-title":"Blood"},{"key":"BF1704776_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","volume":"102","author":"T Fukuda","year":"2003","unstructured":"Fukuda T, Boeckh M, Carter RA et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003; 102: 827\u2013833.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704776","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704776.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704776.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:42:32Z","timestamp":1648078952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,31]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3,1]]}},"alternative-id":["BF1704776"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704776","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,31]]},"assertion":[{"value":"7 June 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}